Company research / PTCT
PTC Therapeutics, Inc. (PTCT)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, PTC Therapeutics, Inc. reported revenue of $1.73B. Revenue grew 114.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.01B.
Key ratios (year ended 2025-12-31)
50.1%
Operating margin
39.4%
Net margin
114.5%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.